These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8187697)

  • 1. Physiologically based pharmacokinetics and cancer risk assessment.
    Andersen ME; Krishnan K
    Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):103-8. PubMed ID: 8187697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: pharmacokinetics and risk assessment with DPX as dosimeter.
    Casanova M; Conolly RB; Heck H d'A
    Fundam Appl Toxicol; 1996 May; 31(1):103-16. PubMed ID: 8998946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
    Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the risk of human cancer associated with exposure to methylene chloride.
    Reitz RH
    Ann Ist Super Sanita; 1991; 27(4):609-14. PubMed ID: 1820733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach for incorporating tissue composition data into physiologically based pharmacokinetic models.
    Pelekis M; Poulin P; Krishnan K
    Toxicol Ind Health; 1995; 11(5):511-22. PubMed ID: 8677516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
    Andersen ME
    Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene chloride induced mouse liver and lung tumours: an overview of the role of mechanistic studies in human safety assessment.
    Green T
    Hum Exp Toxicol; 1997 Jan; 16(1):3-13. PubMed ID: 9023569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of
    Clewell HJ; Campbell JL; Van Landingham C; Franzen A; Yoon M; Dodd DE; Andersen ME; Gentry PR
    Inhal Toxicol; 2019; 31(13-14):468-483. PubMed ID: 31992090
    [No Abstract]   [Full Text] [Related]  

  • 11. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of quantitative modelling in methylene chloride risk assessment.
    Rhomberg L
    Toxicology; 1995 Sep; 102(1-2):95-114. PubMed ID: 7482565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue dosimetry, physiologically-based pharmacokinetic modeling, and cancer risk assessment.
    Andersen ME
    Cell Biol Toxicol; 1989 Dec; 5(4):405-15. PubMed ID: 2627676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
    Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human health effects of dichloromethane: key findings and scientific issues.
    Schlosser PM; Bale AS; Gibbons CF; Wilkins A; Cooper GS
    Environ Health Perspect; 2015 Feb; 123(2):114-9. PubMed ID: 25325283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations.
    David RM; Clewell HJ; Gentry PR; Covington TR; Morgott DA; Marino DJ
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):55-65. PubMed ID: 16439044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches for applications of physiologically based pharmacokinetic models in risk assessment.
    Thompson CM; Sonawane B; Barton HA; DeWoskin RS; Lipscomb JC; Schlosser P; Chiu WA; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2008 Aug; 11(7):519-47. PubMed ID: 18584453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of three physiologically based pharmacokinetic (PBPK) modeling tools for emergency risk assessment after acute dichloromethane exposure.
    Boerleider RZ; Olie JD; van Eijkeren JC; Bos PM; Hof BG; de Vries I; Bessems JG; Meulenbelt J; Hunault CC
    Toxicol Lett; 2015 Jan; 232(1):21-7. PubMed ID: 25455448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interspecies extrapolation.
    Kenyon EM
    Methods Mol Biol; 2012; 929():501-20. PubMed ID: 23007441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures.
    Haddad S; Béliveau M; Tardif R; Krishnan K
    Toxicol Sci; 2001 Sep; 63(1):125-31. PubMed ID: 11509752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.